Press Releases

ACD/Labs, an informatics company that develops and commercializes software in support of digitalized R&D, today announced the release of version 2024 of Spectrus Platform applications. Supporting digital transformation projects and enabling organizations to leverage their R&D data in AI/ML applications...

Authenticx, the new standard in healthcare for listening to customer voices at scale, has released its 2024 Customer Voices in Healthcare Report. The fifth edition of the report highlights the impact of conversation data and how AI unlocks the power of this data source to transform healthcare processes, decrease customer friction, and...

Ahead of CPHI Milan – the world’s largest pharma event, held at Fiera Milano  – new insights from the CPHI Annual Industry Survey reveal that the pharma sector is on the cusp of a major shift, with approvals for complex molecules expected to outpace those for small molecules for the first time. In...

Leading global technology solutions partner, Envision Pharma Group, has launched its new data and analytics management solution, EnvisionOne Insights, to harness the full power of big data in medical affairs technology. This innovation represents a foundational shift in how...

Temperature-controlled container specialists Tower Cold Chain and CRYOPDP have partnered to enhance their product offerings to the pharmaceutical supply chain. The collaboration aims to provide an expanded range of solutions, specifically for clinical research, to address the evolving needs...

Seeq, a leader in industrial analytics and AI, and Vertix Technologies SAC, a solutions-driven company specializing in Industry 4.0, digital transformation and advanced analytics for the process industries, jointly announce the appointment of Vertix as the first Seeq Master...

VS-041, a novel and potentially life-saving  treatment for heart failure, developed by Vasa Therapeutics, a San Diego-based biotechnology  company, has reached a major clinical milestone with the first human subjects dosed at Quotient  Sciences’ Nottingham, UK clinic. In this phase, Quotient Sciences’ Translational Pharmaceutics® platform was selected to accelerate  the drug into first-in-human (FIH) trials. Quotient Sciences’ on-demand manufacture of...